Diphenhydramine Citrate; Ibuprofen Patent Expiration
Diphenhydramine Citrate; Ibuprofen is Used for treating pain-associated sleep disturbances. It was first introduced by Haleon Us Holdings Llc
Diphenhydramine Citrate; Ibuprofen Patents
Given below is the list of patents protecting Diphenhydramine Citrate; Ibuprofen, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Advil Pm | US8263647 | Treatment of sleep disturbances |
May 30, 2022
(Expired) | Haleon Us Holdings |
Diphenhydramine Citrate; Ibuprofen's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List